St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Also called: extracranial germ cell tumor
Cells form the reproductive system as a fetus grows in the uterus. These cells can grow into germ cell tumors, also called gonadal germ cell tumors. Germ cell tumors may be cancerous (malignant) or noncancerous (benign).
Germ cells are usually in the reproductive organs. But they can sometimes travel to other parts of the body and cause tumors. These tumors are called extragonadal germ cell tumors.
Germ cell tumors are rare. They are more common in people with certain inherited disorders (passed down through families). They are also more common in males with a history of undescended testicles.
Germ cell tumors are most common in babies and teens.
Find out more about germ cell tumors on the Together by St. Jude™ online resource.
Surgeons try to remove all of the germ cell tumors. Chemotherapy (chemo) is used to kill any cancer cells that are left. Chemo also stops cancer cells from growing.
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults with germ cell tumors. Learn more about clinical research at St. Jude.
Study goal:
The main goal of this study is to test new experimental drugs in hopes of finding a treatment that may work against tumors that have come back or that have not responded to standard therapy in children, adolescents and young adults.
Age:
12 months to 30 years old
Study goal:
The main purpose of 3CAR is to find out if this type of immunotherapy is safe for pediatric patients with solid tumors. We also want to learn if it is effective in fighting solid tumors.
Age:
Up to 21 years old
Study goal:
Watch patients with low-risk germ cell tumors, after tumor removal, treats their tumor as well as if they got the usual treatment of chemotherapy and/or more surgery if needed.
Age:
Standard Risk Group 1: less than 11 years old; Standard risk Group 2: ages 11–25
Study goal:
The purpose of this study is to find out if accelerated chemotherapy will treat germ cell tumors as well as standard. We will also see if both treatments have similar side effects and are well tolerated.
Age:
Ages 11–45 years
Study goal:
To find out whether repotrectinib is safe to use in children and young adults and whether it might work against tumors.
Age:
Up to 25 years old
St. Jude provides the highest quality of care for patients with germ cell tumors:
St. Jude offers a dedicated team of specialists to meet the needs of children with cancer, including:
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334